Pulmonary fibrosis associated with anti-neutrophil cytoplasmic antibody-positive vasculitis;Fibrosis pulmonar asociada a vasculitis con anticuerpos anticitoplasmáticos positivos

Medicina (Argentina)

Volumn 72, Issue 4, 2012, Pages 329-331

  Casares, Marcelo Fernández ^a   González, Alejandra ^a   Caputo, Flavia ^a   Bottinelli, Yanina ^a   Nastavi, Patricia ^b   Zamboni, Marcelo ^a  

^a HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

^b Servicio de Clinica Medica de Hospital Nacional Professor Dr Alejandro Posadas   (Argentina)

Author keywords

ANCA; Pulmonary fibrosis; Vasculitis

Indexed keywords

ANCA ASSOCIATED VASCULITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; IMMUNOLOGY; LUNG FIBROSIS; TOMOGRAPHY;

AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FATAL OUTCOME; HUMANS; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; PULMONARY FIBROSIS;

EID: 84865148687     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed) 1982; 285: 606.
2. Wilde B, van Paasen P, Witzke O, Tervaert JW. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int 2011; 79: 599-612.
3. Tervaert JW, Goldschmeding R, Elema JD, et al. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 1990; 33: 1264-1272.
4. Hervier B, Pagnoux C, Agard C, et al. Pulmonary fibrosis associated with ANCA positive vasculitides: retrospective study of 12 cases and review of the literature. Ann Rheum Dis 2009; 68: 404-407.
5. Homma S, Matsushita H, Nakata K. Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology 2004; 9: 190-196.
6. Nozu T, Kondo M, Suzuki K, Tamaoki J, Nagai A. A comparison of the clinical features of ANCA positive and ANCA-negative idiopathic pulmonary fibrosis patients. Respiration 2009; 77: 407-415.
7. Foulon G, Delaval P, Valeyre D, et al. ANCA-associated lung fibrosis: analysis of 17 patients. Respir Med 2008; 102: 1392-1398.
8. Tzelepis GE, Kokosi M, Tzioufas A, et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 2010; 36: 116-121.
9. Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE. Pulmonary fibrosis as an unusual clinical manifestation of a pulmonaryrenal vasculitis in elderly patients. Mayo Clin Proc 1990; 65: 847-856.
10. Arimura Y, Minoshima S, Tanaka U, et al. Pulmonary involvement in patients with myeloperoxidase specifc-antineutrophil cytoplasmic antibody. Ryumachi 1995; 35: 46-55.
11. Bhanji A, Karim M. Pulmonary fibrosis - an uncommon manifestation of anti-myeloperoxidasa - positive vasculitis? NTD Plus 2010; 3: 351-353.
12. Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classifcation of vasculitis. Arthritis Rheum 1990; 33: 1065-1067.
13. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classifcation of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007; 66: 222-227.
14. Yamada H. ANCA associated lung fibrosis. Semin Respir Crit Care Med 2011; 32: 322-327.